Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 500 6th Ave NW NEW PRAGUE MN 56071 |
Tel: | 1-617-8779641 |
Website: | https://smartvest.com |
IR: | See website |
Key People | ||
James L. Cunniff President, Chief Executive Officer, Director | Bradley M. Nagel Chief Financial Officer, Treasurer, Company Secretary |
Business Overview |
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting. |
Financial Overview |
For the nine months ended 31 March 2024, Electromed Inc revenues increased 16% to $39.9M. Net income increased 56% to $3.3M. Revenues reflect Home Care-Commercial segment increase of 39% to $17.7M, Homecare-Medicare Supplemental segment increase from $1.1M to $3.4M. Net income benefited from Interest Income increase from $37K to $293K (income), Research and development decrease of 22% to $480K (expense). |
Employees: | 170 as of Jun 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $134.31M as of Mar 31, 2024 |
Annual revenue (TTM): | $53.50M as of Mar 31, 2024 |
EBITDA (TTM): | $6.56M as of Mar 31, 2024 |
Net annual income (TTM): | $4.36M as of Mar 31, 2024 |
Free cash flow (TTM): | $4.79M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 8,655,727 as of May 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |